EUVIMEDEUVIMED entdecken
Crossref

Targeting SARS‐CoV‐2 Proteins: In Silico Investigation with Polypyridyl‐Based Zn(II)‐Curcumin Complexes

Vedant Gawande, Rajesh Kushwaha iD, Arif Ali Mandal, Samya Banerjee iD

ChemBioChem · 2024

DOI: 10.1002/cbic.202400612 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ChemBioChem, 2024. Verfasst von Vedant Gawande und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Indian Institute of Technology (BHU), Varanasi, Uttar Pradesh, 221005, India. Hauptthemen laut MEDLINE: SARS-CoV-2, Zinc, Molecular Docking Simulation, Curcumin. Die Arbeit nennt 73 Literaturangaben. Gefördert von: DST, Government of India.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Herein, we have selected eight Zn(II)‐based complexes viz ., [Zn(bpy)(acac)Cl] ( 1 ), [Zn(phen)(acac)Cl] ( 2 ), [Zn(dppz)(acac)Cl] ( 3 ), [Zn(dppn)(acac)Cl] ( 4 ), [Zn(bpy)(cur)Cl] ( 5 ), [Zn(phen)(cur)Cl] ( 6 ), [Zn(dppz)(cur)Cl] ( 7 ), [Zn(dppn)(cur)Cl] ( 8 ), where bpy=2,2′‐bipyridine, phen=1,10‐phenanthroline, dppz=benzo[i]dipyrido[3,2‐a:2′,3′‐c]phenazine, dppn=naphtho[2,3‐i]dipyrido[3,2‐a:2′,3′‐c]phenazine, acac=acetylacetonate, cur=curcumin and performed in silico molecular docking studies with the viral proteins, i. e., spike protein (S), Angiotensin‐converting enzyme II Receptor protein (ACE2), nucleocapsid protein (N), main protease protein (M pro ), and RNA‐dependent RNA polymerase protein (RdRp) of SARS‐CoV‐2. The binding energy calculations, visualization of the docking orientation, and analysis of the interactions revealed that these complexes could be potential inhibitors of the viral proteins. Among complexes 1 – 8 , complex 6 showed the strongest binding affinity with S and ACE2 proteins. 4 exerted better binding affinity in the case of the N protein, whereas 8 presented the highest binding affinities with M pro and RdRp among all the complexes. Overall, the study indicated that Zn(II) complexes have the potential as alternative and viable therapeutic solutions for COVID‐19.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SARS-CoV-2ZincMolecular Docking SimulationCurcuminCoordination ComplexesCoronavirus 3C ProteasesAntiviral AgentsHumansSpike Glycoprotein, CoronavirusAngiotensin-Converting Enzyme 2Protein BindingBinding SitesCOVID-19Coronavirus Nucleocapsid ProteinsCOVID-19 Drug TreatmentPyridinesPhosphoproteins

Stichwörter der Autor:innen

Antiviral agentsComputational studiesMolecular dockingSARS-CoV-2 virusZn(II) complexes

Substanzen

ZincCurcuminCoordination ComplexesCoronavirus 3C ProteasesAntiviral Agentsspike protein, SARS-CoV-2Spike Glycoprotein, CoronavirusAngiotensin-Converting Enzyme 2ACE2 protein, humanCoronavirus Nucleocapsid Proteins

Autor:innen und Institutionen

  • Department of Chemistry, Indian Institute of Technology (BHU), Varanasi, Uttar Pradesh, 221005, India.

ORCID-Profile: Rajesh Kushwaha, Samya Banerjee

Förderung

  • DST, Government of India

Zitieren

APA

Gawande, V., Kushwaha, R., Mandal, A. A., & Banerjee, S. (2024). Targeting SARS‐CoV‐2 Proteins: In Silico Investigation with Polypyridyl‐Based Zn(II)‐Curcumin Complexes. ChemBioChem. https://doi.org/10.1002/cbic.202400612

Vancouver

Gawande V, Kushwaha R, Mandal AA, Banerjee S. Targeting SARS‐CoV‐2 Proteins: In Silico Investigation with Polypyridyl‐Based Zn(II)‐Curcumin Complexes. ChemBioChem. 2024. doi:10.1002/cbic.202400612

BibTeX
@article{Gawande2024,
  author = {Gawande, Vedant and Kushwaha, Rajesh and Mandal, Arif Ali and Banerjee, Samya},
  title = {Targeting SARS‐CoV‐2 Proteins: In Silico Investigation with Polypyridyl‐Based Zn(II)‐Curcumin Complexes},
  journal = {ChemBioChem},
  year = {2024},
  doi = {10.1002/cbic.202400612}
}
Kostenlos starten →